Literature DB >> 34937949

Axicabtagene effective in indolent NHL.

Peter Sidaway1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34937949     DOI: 10.1038/s41571-021-00596-9

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

Authors:  Caron A Jacobson; Julio C Chavez; Alison R Sehgal; Basem M William; Javier Munoz; Gilles Salles; Pashna N Munshi; Carla Casulo; David G Maloney; Sven de Vos; Ran Reshef; Lori A Leslie; Ibrahim Yakoub-Agha; Olalekan O Oluwole; Henry Chi Hang Fung; Joseph Rosenblatt; John M Rossi; Lovely Goyal; Vicki Plaks; Yin Yang; Remus Vezan; Mauro P Avanzi; Sattva S Neelapu
Journal:  Lancet Oncol       Date:  2021-12-08       Impact factor: 41.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.